Search filters

List of works by Robert Bissonnette

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document

scientific article published on 01 November 2018

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis

scientific article published on 01 November 2018

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis

scientific article published on 01 November 2018

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

scientific article published on 05 January 2020

Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients

scientific article published on 05 September 2018

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

scientific article published on 22 July 2018

Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study

scientific article published on 17 April 2019

Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis

scientific article published on 01 September 2019

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

scientific article published on 25 June 2019

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale

scientific article published on 27 November 2020

Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals

scientific article published on 03 May 2019

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

scientific article published on 26 July 2019

Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension study

scientific article published on 5 June 2017

Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis

scientific article published on 09 July 2020

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study

scientific article published on 06 May 2019

Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.

scientific article

Ultraviolet B-induced immunosuppression is not associated with receptor activator of nuclear factor kappa B ligand upregulation in human skin

scientific article published on 09 October 2018

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

scientific article published on 21 November 2018

Paulina is supported by:

About Paulina

Help